|2.||Depressive Disorder (Melancholia)
|4.||Bipolar Disorder (Mania)
|1.||Masel, Eva K: 1 article (12/2015)|
|2.||Porstner, Dagmar: 1 article (12/2015)|
|3.||Heck, Ursula: 1 article (12/2015)|
|4.||Inamoto, Atsuko: 1 article (01/2015)|
|5.||Tani, Masayuki: 1 article (01/2015)|
|6.||Hori, Koji: 1 article (01/2015)|
|7.||Kitajima, Yuka: 1 article (01/2015)|
|8.||Hosoi, Misa: 1 article (01/2015)|
|9.||Hachisu, Mitsugu: 1 article (01/2015)|
|10.||Izuno, Takuji: 1 article (01/2015)|
|1.||Dexamethasone (Maxidex)FDA LinkGeneric
04/01/1982 - "The dexamethasone suppression test in two patients with severe depressive pseudodementia."
02/01/1983 - "It seems likely that many of the affective syndromes in the elderly like senile melancholia, manic depressive illness, pseudodementia, and masked depression belong to the group of endogenous depressions, and can be identified by a constellation of clinical symptoms (endogenous or endogenomorphic profile), abnormal dexamethasone suppression test (DST) (at least 50%), and positive response to treatment with antidepressant medication. "
|2.||Ibuprofen (Motrin)FDA LinkGeneric
01/01/2003 - "Pseudodementia associated with use of ibuprofen."
01/01/2003 - "Using the Naranjo probability scale, we reasoned that the patient's dementia-like syndrome could be attributed to the use of ibuprofen because pseudodementia appeared after the suspected drug was administered, improved when the drug was discontinued, reappeared when the drug was readministered, had no apparent alternative cause, manifested similarly after each exposure to ibuprofen, and was confirmed by the family's observation after both episodes. "
|3.||Sertraline (Zoloft)FDA LinkGeneric
08/01/2011 - "She was initially treated with memantine, but as time progressed it became more evident she was experiencing depression and a "pseudodementia," which was treated with sertraline. "
01/01/2001 - "Sertraline and reboxetine association in depressive pseudodementia: good cardiovascular effects."
02/01/2009 - "The plastic surgeon rarely encounters patients with factitious disorders. "
01/01/2008 - "We outline clues to the recognition of factitious disorders and steps the plastic surgeon can take to initiate appropriate treatment, which may reduce the risk of litigation."
01/01/2008 - "Factitious disorders: potential litigation risks for plastic surgeons."
03/01/1997 - "First, although parkinsonism is known to be preceded by depressive episodes, particularly in a subgroup of younger patients, the symptoms of the elderly patient whose Parkinson's disease is foreshadowed by depression can mimic depressive pseudodementia, potentially leading to diagnostic confusion. "
01/01/1985 - "The term pseudodementia is applied to the range of functional psychiatric conditions such as depression, schizophrenia and hysteria that may mimic organic dementia, but are essentially reversible on treatment. "
|6.||antineoplaston A10 (A 10)IBA
03/01/1989 - "A case of pseudodementia in a 10 year old boy was first reported in 1981. "
03/01/1989 - "Ganser syndrome in a 10 year old boy--an 8 year follow up."
12/01/1981 - "A case of pseudodementia, occurring in a 10 year old boy following a minor head injury and associated with a claim for compensation, is presented. "
|7.||Technetium Tc 99m Exametazime (Ceretec)FDA Link
05/01/2002 - "Through the comparison of the 99mTc-HMPAO single photon emission computed tomography (SPECT) image of depressive pseudodementia subjects, healthy comparison subjects, depressed subjects free of cognitive impairment, and dementia of Alzheimer's type (DAT) subjects, we aimed to see part of pathophysiology of the depressive pseudodementia of elderly patients. "
|8.||Biological Markers (Surrogate Marker)IBA
|9.||Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
|10.||Psychotropic Drugs (Psychoactive Drugs)IBA
01/01/1995 - "Long-term cognitive changes were observed in 8 depressed patients whose pretreatment cognitive impairment (depressive dementia or pseudodementia) resolved after treatment with ECT. "
04/01/1989 - "We found significant group differences on waking EEGs between those mixed patients who did well after treatment for depression (depressive pseudodementia) compared to patients having dementia with secondary depression. "
04/08/1996 - "[Prolonged pseudodementia after treatment with tricyclic antidepressive agents and electroconvulsive therapy]."
|3.||Palliative Care (Palliative Medicine)
|4.||Electric Stimulation Therapy (Electrotherapy)
|5.||Drug Therapy (Chemotherapy)
02/01/2003 - "Appropriate indications for PEG placement are 1) Esophageal obstruction (e.g., esophageal cancer), 2) Neurologic etiology of dysphagia without obstruction (e.g., status post cerebrovascular accident, pseudobulbar palsy), 3) Prolonged refusal to swallow without evidence of concomitant terminal illness (e.g., protracted pseudodementia due to severe depression), 4) Supplemental nutrition for patients undergoing chemotherapy or radiation therapy. "